| Authors: |
Verhoef G; University Hospital Leuven, Belgium gregor.verhoef@uzleuven.be., Robak T; Medical University of Lodz, Copernicus Memorial Hospital, Poland., Huang H; Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China., Pylypenko H; Cherkassy Regional Oncology Center, Ukraine., Siritanaratkul N; Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand., Pereira J; Hospital das Clinicas da Faculdade de Medicina da USP, São Paolo, Brazil., Drach J; University of Vienna, Vienna General Hospital, Austria., Mayer J; Masaryk University Hospital Brno, Czech Republic., Okamoto R; Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Japan., Pei L; Janssen Research & Development, LLC, Raritan, NJ, USA., Rooney B; Janssen Research & Development, High Wycombe, Buckinghamshire, UK., Cakana A; Janssen Research & Development, High Wycombe, Buckinghamshire, UK., van de Velde H; Millennium Pharmaceuticals, Inc., Boston, MA, USA., Cavalli F; Oncology Institute of Southern Switzerland, Ospedale San Giovanni, Bellinzona, Ticino, Switzerland. |
